BOERNE, TX – June 28, 2011 – Following an agreement reached May 23, 2011, Stanbio Laboratory – a leader in medical testing and diagnostic devices – has been purchased by United Kingdom-based EKF Diagnostics Holdings plc. The transaction was formally completed June 17, 2011.
“The agreement with EKF Diagnostics Holdings is a good fit with our aggressive global growth strategy,” said William R. Pippin, President of Stanbio Laboratory. “Our current worldwide presence will be enhanced considerably under the EKF umbrella. EKF will benefit from the Stanbio Laboratory 50-plus year history of serving the diagnostic and clinical chemistry markets with high-performance products backed by a brand known for its quality focus,” Pippin added.
EKF Diagnostics Holdings Chief Executive Officer Julian Baines said, “The acquisition of Stanbio is transformational for EKF. We now have access to the lucrative U.S. point-of-care market and we’re delighted to have the respected Stanbio portfolio and operational assets as part of the EKF Diagnostics Holdings family.”
Other recent EKF Diagnostics Holdings acquisitions include EKF-diagnostic GmbH, Quotient Diagnostics Limited and Argutus Medical Limited. These portfolio additions are strategically aimed at serving the growth-oriented point-of-care diagnostic markets including the increasingly robust diabetes testing market.
Founded in 1960 and headquartered in Boerne, Texas, Stanbio Laboratory manufactures and markets medical testing and diagnostic devices including clinical chemistry, pregnancy, strep A, serology, urinalysis, and point-of-care hemoglobin tests. Stanbio Laboratory’s Quality System is ISO 13485 registered and its facility operates under USFDA current GMP requirements. Stanbio also offers OEM and private labeling capabilities and distributes products in over 125 countries worldwide. This year the company celebrates its 51st year in business. To find out more about Stanbio, review its news, or learn more about its products, visit www.stanbio.com.
EKF Diagnostics Holdings plc focuses on the design, development, manufacture, and sale of diagnostic instruments and reagents primarily in Germany, Poland, and Russia. The company also sells ancillary products, including a line of proprietary cuvettes, which are transparent containers that contain specimen samples in the device. It offers its products to the professional clinical and research laboratories, doctors’ offices, sports clinics, and athletic testing sites. The company is based in London, the United Kingdom.
